OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statin use and safety concerns: an overview of the past, present, and the future
Rubina Mulchandani, Tanica Lyngdoh, Ashish Kumar Kakkar
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 8, pp. 1011-1024
Closed Access | Times Cited: 22

Showing 22 citing articles:

The Effect of Rosuvastatin and Calcitriol on Preventing Voice Change After Thyroidectomy: A Randomized Controlled Trial
Mehdi Ghasemian, Mehrdad Karajizadeh, Mohammad Reza Yousefi, et al.
Journal of Voice (2025)
Closed Access

Statins and non-alcoholic fatty liver disease: A concise review
Evelyn Nunes Goulart da Silva Pereira, Ricardo Franco, Raul D. Santos, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 183, pp. 117805-117805
Open Access

Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research
Sanjana Misra, Tanica Lyngdoh, Rubina Mulchandani
Indian Heart Journal (2022) Vol. 74, Iss. 5, pp. 341-350
Open Access | Times Cited: 15

MicroRNA-206 as a potential cholesterol-lowering drug is superior to statins in mice
C. Li, Jing Tian, Ningning Liu, et al.
Journal of Lipid Research (2024) Vol. 65, Iss. 7, pp. 100576-100576
Open Access | Times Cited: 2

Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles
Lin Bai, Yafei Wang, Jia Huo, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 17

Statins and peripheral neuropathy in diabetic and non-diabetic cases: a systematic review
Mahla Daliri, Thomas P. Johnston, Amirhossein Sahebkar
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 5, pp. 593-611
Open Access | Times Cited: 4

Landscape of Statin as a Cornerstone in Atherosclerotic Cardiovascular Disease
Cheng Yang, Yongjian Wu, Jie Qian, et al.
Reviews in Cardiovascular Medicine (2023) Vol. 24, Iss. 12, pp. 373-373
Open Access | Times Cited: 4

Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance
Jian‐Jun Li, Kefei Dou, Zhiguang Zhou, et al.
Clinical Pharmacology & Therapeutics (2024) Vol. 115, Iss. 5, pp. 954-964
Closed Access | Times Cited: 1

In vivo and in silico studies of membrane-stabilizing and clot lysis activities of Trachyspermum ammi
Md. Showkoth Akbor, Mst. Farjanamul Haque, Ahmmed Zunaed Rahman, et al.
Food Chemistry Advances (2024) Vol. 5, pp. 100789-100789
Open Access | Times Cited: 1

Cholesterol Management in Neurology: Time for Revised Strategies?
Felicia Liana Andronie-Cioară, Anamaria Jurcău, Maria Carolina Jurcău, et al.
Journal of Personalized Medicine (2022) Vol. 12, Iss. 12, pp. 1981-1981
Open Access | Times Cited: 6

Fatal hepatic failure following atorvastatin treatment: A case report
Huajun Wang, Shiyi Liu, Chenjie Zhou, et al.
Medicine (2023) Vol. 102, Iss. 19, pp. e33743-e33743
Open Access | Times Cited: 3

Targeting EBV‐encoded products: Implications for drug development in EBV‐associated diseases
Mengwen Lv, Yuan Ding, Yan Zhang, et al.
Reviews in Medical Virology (2023) Vol. 34, Iss. 1
Closed Access | Times Cited: 3

Statin protects men but not women with HIV against loss of muscle mass, strength, and physical function: a pilot study
José David G. Cárdenas, Vitor H. F. Oliveira, Ana L. Borsari, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 2

Unravelling the risk factors and treatment patterns of dyslipidemia in India (UNICORN study)
Mayur Mayabhate, Akhilesh Sharma
International Journal of Research in Medical Sciences (2024) Vol. 13, Iss. 1, pp. 164-172
Open Access

Systemic Statin Use and Pulp Chamber Calcification: A Pilot Retrospective Case Control Study Using Cone-Beam Computed Tomography
Selen Nihal Sisli, Birgül Özaşır, Tufan Özaşir, et al.
Medical Principles and Practice (2024), pp. 1-10
Open Access

Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens
Zizo Lusiki, Dirk Blom, Nyarai D. Soko, et al.
OMICS A Journal of Integrative Biology (2023) Vol. 28, Iss. 6, pp. 261-279
Open Access | Times Cited: 1

Statins in liver cirrhosis in a developing country: benefits overweigh the risk?
Jhean Gabriel Gonzáles Yovera, Marcio José Concepción‐Zavaleta, Diego Martín Moreno Marreros, et al.
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 12, pp. 1651-1652
Open Access | Times Cited: 1

Effect of statins on risk and mortality of urologic malignancies: Protocol of an umbrella review
Xinyu Zhai, Pengsheng Yi, Xitao Wang, et al.
PLoS ONE (2022) Vol. 17, Iss. 3, pp. e0264076-e0264076
Open Access | Times Cited: 1

Dyslipidemias
Cristiane Almeida Soares Cattani, Renata Heck
Springer eBooks (2023), pp. 1041-1052
Closed Access

Statins-induced hepatotoxicity: still more questions than answers
Rubina Mulchandani, Tanica Lyngdoh, Ashish Kumar Kakkar
Expert Opinion on Drug Safety (2020) Vol. 19, Iss. 12, pp. 1653-1654
Closed Access

Familial hypercholesterolemia
Shifa Jebari‐Benslaiman, Unai Galicia-García, Asier Larrea‐Sebal, et al.
Elsevier eBooks (2022), pp. 501-524
Closed Access

Page 1

Scroll to top